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We describe the effect of splenic irradiation (SI) (0,5-1 Gy weekly) on lymphocyte 
subpopulations for 7 patients with progressive B chronic B-lymphocytic leukemia (B- 
CLL). Using specific cellular characteristics we could distinguish normal from abnor- 
mal cells. The irradiation resulted in a decrease of lymph node size, reduction in spleen 
volume and decrease in peripheral blood lymphocytes. The one exception was a patient 
with a prolymphocytoid transformation of B-CLL. For 3 patients SI had to be 
interrupted or stopped because of severe cytopenia. Quantitation of malignant B cells 
and normal T lymphocytes revealed that the total irradiation dose which resulted in a 
specific decrease of malignant lymphocytes varied from patient to patient. Normal 
T-cell subpopulations, which were increased before SI, decreased to normal or abnor- 
mally low values during SI. In previously untreated patients, natural killer (NK) cell 
numbers decreased more rapidly than T-cell subpopulations. For 2 patients refractory 
to chemotherapy an increase of NK cells was observed upon SI. 
Accepted for  publication June 20, 1988 
In chronic B-lymphocytic leukemia (B-CLL), irra- 
diation of thymus, total bone marrow or spleen 
has been suggested as an effective alternative to 
chemotherapy and glucocorticosteroid treatment 
(1, 2). Of the various irradiation procedures, 
splenic irratiation (SI) has resulted in the best 
reduction of tumor load (2). No serious side 
effects of SI have been reported. Even with low 
irradiation doses, SI results in the destruction of a 
large proportion of the malignant cells. It has also 
been reported that SI results in a normalization of 
T-lymphocyte subpopulations (3). 
Until now, no effort has been made to estab- 
lish the effect of SI on different lymphocyte 
subsets, and to determine the dose of irradiation 
which yields an optimum benefit for the patients 
without side effects. We decided to compare the 
effects of SI on both malignant B lymphocytes 
and on normal T-lymphocyte subpopulations as 
a function of radiation dose received during the 
SI course. In this study 7 patients were treated 
with SI. We have used multiparameter flow 
cytometry to quantify the occurrence of malig- 
nant cells and to distinguish them from normal 
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TABLE 1 
Clinical details of patients 
Patient Sex Age stage Rai Comment 
F 60 
M 66 
M 47 
M 53 
M 47 
M 72 
M 62 
111 
IV newly diagnosed 
IV newly diagnosed 
I1 newly diagnosed 
IV newly diagnosed 
IV 
slowly progressive disease for 3 yr 
4 yr treated with chemotherapy* (3 COP courses and 
chlorambucil as maintenance treatment) progression 
of disease under treatment 
6 yr treated with chemotherapy' (7 COP courses and 
chlorambucil as maintenence treatement) prolympho- 
cvtoid transformation of the disease 
IV 
F = female; M = male; * treatment was stopped 1 month prior to SI. 
CD3-, CD4-, CD8-, HNK-1- and CD16-positive 
lymphocytes during irradiation. 
Material and methods 
Patients and controls 
7 B-CLL patients were included in this study. The 
diagnosis was confirmed by the finding of a monoclo- 
nal proliferation of B lymphocytes in the peripheral 
blood and more than 40% lymphocytes in the bone 
marrow. Clonality was demonstrated by expression of 
a single immunoglobulin light chain, either h or K, on 
the surface. One of the patients showed an increased 
number of prolymphocytoid cells, indicating a pro- 
lymphocytoid transformation of B-CLL (4). The main 
clinical details of the patients are summarized in Table 
1. As controls, 30 healthy donors were used whose ages 
varied from 22 to 85 yr. 
Splenic irradiation 
The schedule of splenic irradiation was identical to 
the one reported by McCann et al (2): patients 
received a weekly dose of 1 Gy up to a total dose of 
10 Gy, except for patient 2 who received a weekly 
dose of 0.5 Gy up to a total dose of 5 Gy. Radiation 
was produced with an 8 MV linear accelerator. 
Administering the irradiation dose took less than 30 
seconds. The irradiation field was established on the 
basis of an abdominal computer tomographic (CT) 
scan and adapted each wk in accordance with the 
clinically approximated spleen size. Blood counts were 
made before each SI in order to determine whether 
irradiation could be tolerated. Lymphocyte sub- 
populations were also determined before irradiation. 
Spleen volume and abdominal and mediastinal lymph 
node sizes were determined from CT scans made 
before and after SI. 
Lymphocyte subpopulation 
determination 
Human blood was collected by venipuncture into vac- 
utainer tubes containing heparin as anticoagulant. 
Lymphocytes were obtained after density separation 
as described in detail elsewhere (5 ) .  Because of the 
low frequency of T lymphocytes in B-CLL patients, 
only direct immunofluorescence staining was used 
with fluorescently labeled monoclonal antibodies. 
This procedure allows detection of lymphocyte sub- 
populations by flow cytometry even if they occur in a 
frequency of only 0.02% (6). The following monoclo- 
nal antibodies were used: Fluorescein (FITC)-labeled 
monoclonal antibodies: CD3 (anti-leu4, Becton 
Dickinson, Amersfoort, The Netherlands.); CD4 
(anti-leu3*), CD16 (anti-leu1 1*) and HNK-1 (anti- 
leu7*); Phycoerythrin (PE)-labeled monoclonal anti- 
bodies: CD8 (anti-leu2a*) and CD5 (anti-leul'). Lym- 
phocyte analysis was carried out the same day irradia- 
tion was performed using the procedure as described 
in detail elsewhere (7). 
Flow cytometric measurements were performed 
under reproducible apparatus conditions by adjusting 
the flow cytometer with standard microspheres. This 
is imperative to  obtain reliable information on the 
amount of cell receptors detected with fluorescently 
labeled mabs. 
Residual monocytes in the preparation were 
excluded from the results by discrimination on for- 
ward and orthogonal light scattering in the flow 
cytometer (7). 
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Figure 1 .  Two-parameter density map of orthogonal light scattering intensity versus the logarithm of fluorescence intensity of 
Phycoerythrin-labeled CD5, for the lymphocytes of patient 1 measured before SI (Figure 1 . I )  and after 3 (1.2), 6 (1.3) and 12 (1.4) 
wk; S1 dose respectively 0, 3,  6 ,  and 10 Gy. Equal numbers of cells were represented in the density maps. 
Results 
Radiation effects on 
blood counts and tumor load 
The effect of SI on total white blood cell count, 
differential granulocyte count, platelet count and 
blood hemoglobin for all patients is summarized in 
Table 2. In the 5 patients not treated previously with 
chemotherapy the total leukocyte count dropped 
very rapidly to normal or subnormal values. In 2 
patients refractory to chemotherapy the total leu- 
kocyte count did not change significantly, or show- 
ed an increase. The effect of SI on platelet count and 
hemoglobin varied considerably from patient to 
patient. In some patients no change was observed, 
in others an increase or decrease was found. Only 4 
of the 7 patients completed the SI course without 
complications. In the other patients the SI course 
had to be interrupted or stopped because of an 
unacceptable decrease of either platelet count or 
hemoglobin. None of the patients had gastrointesti- 
nal side effects due to SI. 
Dimensions of mediastinal lymph node and 
lymph nodes at the liverhilus, paraaortic and para- 
iliac regions were determined from CT scans (Table 
2). Submandibular, cervical, supraclavicular, axil- 
larandinguinallymphnodenumberanddimensions 
were determined by clinical examination (Table 2). 
The decrease in lymphnode dimensions resulting 
from SI varied from patient to patient. In patient 7 
an increase of lymph node sizes was observed. 
Discrimination of T cells 
and malignant B cells 
Thereceptors for themonoclonalantibodyCD5 are 
present on T cells and malignant B cells of B-CLL 
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Figure 2. Absolute number of lymphocyte subpopulations determined before SI, before the 4th. 7th and 10th SI and 2 wk after the 
10th (last) SI, unless otherwise indicated. Results are given for patient 1 to 7 in respectively Figure 2.1 to 2.7. In 2.8 lymphocyte 
subpopulations of 1 healthy individual followed during the same time period and the range of the absolute number of lymphocyte 
subpopulations as determined for 30 healthy individuals are given. Note the logarithmical scale. Explanation of the symbols: 
X-----X (CD5-CD3) (malignant cells), U CD3 (T cells), 0 4  CD4 (T-helper cells), U--O CD8 (T-suppressor/ 
cytotoxic cells), W -  . - W  CD16 (NK cells), O.....O HNK-1 (subset NK cells and cytotoxic T cells), -"p interruption of SI, A 
no SI, t last S1 
patients (8, 9, 10, 11). We have found that the 
CD5 receptor density differs strongly for both 
populations: the mean CD5 fluorescence signal 
of T cells is more than 10 times as large as that 
of the malignant B cells. This was found for 15 
B-CLL patients investigated in our laboratory. 
Using this observation we could determine the 
differential effect of SI on T cells and malig- 
nant B cells. This is illustrated in Figure 1, 
where two-parameter density maps of orthogo- 
nal light scattering intensity versus the log- 
arithm of the fluorescence intensity of CD5 are 
given for patient 1. Determinations were made 
before SI and after 3, 6 and 10 Gy had been 
received (Figure 1.1 to 1.4 respectively, each of 
which contains data from an equal number of 
cells). In Figure 1.1 the majority of lympho- 
cytes showed a relative low fluorescence inten- 
sity, a property of malignant B cells. In Figure 
1.2 a second population with a high fluores- 
cence intensity could clearly be seen. These 
were T cells which possess high densities of 
CD5 receptors. Figures 1.3 and 1.4 show a 
progressive increase of the relative number of T 
cells. Malignant B cells were almost absent 
after the irradiation course was completed (Fig- 
ure 1.4). This Figure clearly illustrates the selec- 
tive lethal effect of SI on malignant B cells. 
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Figure 3. Relative sensitivity to SI of the different lymphocyte subpopulations. Occurrence of the absolute number of 
lymphocyte subpopulations during and after the SI (before 4th, 7th, 10th and 2 wk after the 10th SI) were compared with the 
absolute number of lymphocytes before S1. Results are given for patient I to 7 in Figure 3.1 to 3.7 respectively. In 3.8 data are 
given for 1 healthy individual followed during an equal time period. Note the logarithmical scale. Explanation of the symbols 
x-----x (CD5-CD3), U .D3, 0-0 CD4, 0-0 CD8, M- . -M CD16, O.....O HNK-I -$- interruption of 
SI, A no SI, t last SI. 
Quantitation of 
lymphocyte subpopulations 
The absolute numbers of different lymphocyte 
subpopulations were detemined immediately 
before lst, 4th, 7th, 10th SI and 2 wk after the last 
SI. Since T cells and malignant B cells were posi- 
tive with the monoclonal antibody CD5 and the 
receptors for the monoclonal antibody CD3 
occurred only on T cells, the percentage of malig- 
nant lymphocytes was defined as the percentage of 
CDS-positive cells minus the percentage of CD3- 
positive lymphocytes. This was not completely 
correct since immature T cells and a small percen- 
tage of normal B cells were also positive with CD5 
and negative with CD3. However, the occurrence 
of these cells in normal individuals was very low 
(less than 0.07 x lo6 ml). 
In Figure 2.1 to 2.7 absolute numbers of dif- 
ferent lymphocyte subpopulations are presented 
for all patients. For comparison, we followed the 
different lymphocyte subpopulations for 1 healthy 
individual during a period equal to the irradiation 
course given to the patients. We also determined 
the normal range of lymphocyte subpopulations 
for 30 healthy donors. These data are given in 
Figure 2.8. 
In all patients, except patient 7, the malignant B 
cells decreased very rapidly following the initiation 
of the irradiation therapy. The absolute effect of 
SI on the malignant cells varied significantly 
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between patients. Normal values of CD5+ B lym- 
phocytes were not reached in any of the patients. 
The absolute numbers of CD3+, CD4+ and 
CD8+ cells were abnormally high or within normal 
values for the 5 patients who had not been treated 
by chemotherapy prior to SI. These numbers fell 
to the normal or subnormal range during the 
course of the SI. In contrast, the CD3+, CD4+ and 
CD8+ lymphocytes in patient 7 (previously treated 
by chemotherapy) were unaffected by SI. There 
was a decrease in number of CD3+, CD4+ and 
CD8+ lymphocytes in patient 6 during SI, fol- 
lowed by a rapid increase immediately after SI. 
In all patients the number of HNK-1+ lympho- 
cytes was elevated before SI. During irradiation 
the number of HNK-1 + lymphocytes decreased in 
the patients. However, in patient 6 the number of 
HNK-1 + cells increased rapidly after the SI course, 
as was observed for the T lymphocytes. 
The numbers of CD16-positive lymphocytes 
(NK cells) determined before SI were increased in 
patients 1 ,2 ,3  and 5 (Figure 2.1,2.2,2.3,2.5) and 
fell within normal range for patients 4, 6 and 7 
(Figure 2.4, 2.6, 2.7). During the irradiation 
course the NK cells dropped below normal values 
except for the patients refractory to chemotherapy 
(6 and 7, Figure 2.6, 7) for whom an increase of 
NK cells was observed. 
A remarkable observation during the SI course 
of patient 3 (Figure 2.3) was that both malignant 
cells and normal lymphocyte subpopulations 
dropped to abnormally low values. For this 
patient the course was interrupted because of 
severe fever for which no source could be found. 
After a delay of 5 wk, the SI was continued. At 
that time, the lymphocyte subpopulations were 
increased to almost normal values, except for the 
NK cells which remained very low. The subsequent 
SI did not significantly change this pattern. 
Relative sensitivity of the 
different lymphocyte subpopulations 
to splenic irradiation (SI) 
The relative sensitivity of the different sub- 
populations to SI in the 7 patients is presented in 
Figure 3.1 to 3.7. For comparisons the variation 
of the different lymphocyte subpopulations is 
given for a healthy individual during an equi- 
valent time period (Figure 3.8). It was clearly 
demonstrated that the malignant cells were the 
cells most sensitive to SI (Figure 3.1-3.5) in pre- 
viously untreated patients: a decrease by a factor 
of 100 to more than 1000 was observed. 
For patients refractory to chemotherapy, the 
effect of irradiation was less selective. In patient 
6 (Figure 3.6) the malignant cells decreased by a 
factor of 20 as compared with normal lympho- 
cytes. In patient 7 (Figure 3.7) there was no 
effect on either the malignant or the T cells. 
A striking reduction in the NK cell fraction 
was observed in patients 1 and 3 (Figure 3.1, 
3.3). This fraction was 10 times more sensitive to 
SI than the CD3-positive T cells. In patient 2 and 
5 (Figure 3.4) no difference between NK cells and 
T cells was found. Previously treated patients (6, 
7, Figure 3.6, 3.7) showed an increase of NK 
cells and a decrease of HNK-I+ lymphocytes 
during treatment. 
Differences in sensitivity of the CD3 + , CD4+, 
CD8+ and HNK1+ cells were significant, but no 
consistent pattern could be discerned in the 
patients studied. 
Discussion 
In this study we evaluated the effect of splenic 
irradiation (SI) on lymphocyte subpopulations of 
7 patients with B-CLL. In agreement with pre- 
vious studies of Aabo et a1 (l), Byhardt et a1 (12) 
and McCann et a1 (3), we showed that, in all 
previously untreated patients, SI resulted in a 
drastic decrease in the number of lymphocytes. 
In one patient with a malignant prolymphocytoid 
transformation of the B-CLL, an increase of 
tumor load in lymph node, spleen and peripheral 
blood was observed in spite of SI. 
The massive lymphocyte loss resulting from 
SI is not fully understood. The decrease of 
spleen size could be explained by the recognized 
destructive effect of irradiation on B cells (13, 
14). To explain the enormous decrease in the 
number of peripheral blood lymphocytes and 
lymph node sizes, the splenic lymphocyte pool 
of the patients has to be larger as compared 
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with the peripheral lymphocyte pool (15). Fur- 
thermore, the lymphocyte traffic from lymph 
nodes and peripheral blood to the spleen has to 
be considerable. 
The effect of SI on normal hematopojesis 
varied significantly between the patients. Hemo- 
globin and platelet counts were seen to 
increase, to decrease, or to remain constant in 
the patients who received SI. In only 4 of the 7 
patients could the entire SI course be given. 
These observations clearly showed that SI was 
not always as free from side effects as was 
reported in other studies (1, 2, 3,  12, 16). In 
those studies a comparable patient population 
and irradiation scheme was used. 
The effect of SI on lymphocyte counts also 
varied between the patients (Figures 2 and 3). 
The observed differences in the effect of SI on 
malignant B cells between the patients could be 
explained by different maturation stages of the 
malignant cells, since the radiosensitivity of B 
cells is dependent on their differentiation stage 
( 1 1 ,  17). 
The decrease of malignant cells was consider- 
ably larger than the decrease of normal T cells 
(Figure 3), which could be explained by the 
greater radiosensitivity of B cells compared with 
T cells (18). The absolute numbers of cells of 
the different T-cell subpopulations which were 
above average before SI decreased during SI to 
lower than normal values for most patients. 
This could disrupt the reactivity of the immune 
system and therefore make patients more sus- 
ceptible to infection. 
Patient 2 received a weekly SI dose of 0.5 
Gy, half the SI dose administered to the other 
patients. Nevertheless, the rate at which malig- 
nant cells decreased was at least as fast as in 
the other patients. The sensitivity of the T cells 
to SI in this patient was less than in the other 
patients. This suggests that it may be worth- 
while to determine the minimal SI dose to 
cause a decrease of malignant B cells with mini- 
mum effects on the T cells. 
At first sight the different T-cell subpopula- 
tions of an individual patient showed a similar 
response to the SI. Although a closer examina- 
tion revealed significant changes in CD4/CD8 
ratios during the irradiation course, we did not 
observe consistent changes in the CD4/CD8 
ratios. This was in contrast with the results of 
McCann et a1 (3) who found a normalization of 
Tp/Ty ratios after SI of B-CLL patients. The 
variation observed in our data indicates that 
one should be careful not to draw conclusions 
based upon a single determination. 
The initial sensitivity of the different T-cell 
subpopulations to SI was comparable for 5 of 
the 7 patients (Figures 3.1, 3.2, 3.4, 3.5, 3.6). 
However, the observation that in patient 3 (Fig- 
ure 3.3) this sensitivity was initially more than 
40 times greater than in the other patients, 
whereas in patient 7 (Fig. 3.7) there was no 
change in T-cell subpopulations at all during 
SI, suggests that not only the radiosensitivity of 
the T cells plays a role in the response of T-cell 
subpopulations to SI. Possible explanations for 
the difference in sensitivity to SI may be: 
1 .  The relative occurrence of T-cell subpopula- 
tions in the spleen of patient 3 was much 
greater than in the other patients, whereas in 
patient 7 relatively few T cells were within 
the spleen. 
2. Radiosensitivity of the T cells of patient 3 
was greater and of patient 7 was less than in 
the other patients. 
3. Immunoregulation of homing and prolifera- 
tion of T cells which respond to changes in 
the number of malignant cells. 
The latter explanation may be the most likely 
one since in patient 7 no response to the num- 
ber of malignant B cells nor to the number of 
T cells was observed upon SI. 
Several authors have described a relative or 
absolute increase of CD8 lymphocytes in 
B-CLL patients resulting in a decreased CD4/ 
CD8 ratio (6, 19, 20, 21, 22, 23, 24). The 
increase of CD8 lymphocytes is often ascribed 
to an increase of the number of CD8 sup- 
pressor lymphocytes. We have reported that in 
B-CLL patients these CD8 lymphocytes mainly 
consist of cytotoxic lymphocytes (5, 6). In the 
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latter study, the hypothesis was put forward 
that these cytotoxic lymphocytes were directed 
specifically against the leukemic cells. This 
might explain the spontaneous remissions some- 
times observed in untreated B-CLL patients 
(25). In this study we found that the absolute 
and relative amounts of cytotoxic lymphocytes 
were abnormally high in all patients before SI, 
supporting the importance of cytotoxic lympho- 
cytes in B-CLL patients. Especially the numbers 
of HNK-1 lymphocytes were very high, indicat- 
ing that the cytotoxic lymphocytes mainly con- 
sist of cytotoxic T cells and not NK cells. This 
was in accordance with the studies of Foa et a1 
(26, 27), although in the latter study a decrease 
of NK cells as compared with healthy donors 
was found. We did not observe such a decrease 
in our patients. 
A remarkable observation was that the NK 
cells identified with CD16 were more sensitive 
to SI than CD3-, CD4-, CD8- and HNK-l-posi- 
tive lymphocytes in patients not treated prior to 
SI. When NK cells do play an active role in the 
natural defence against leukemic cells, a major 
part of this defence is destroyed because of the 
selective disappearance of NK cells through SI. 
Patients refractory to chemotherapy showed an 
opposite effect of the SI on cytotoxic lympho- 
cyte subpopulations, namely an increased num- 
ber of NK cells (CD16) and a decreased num- 
ber of HNK-1 lymphocytes (identifying a subset 
of NK cells and T cell-dependent cytotoxic lym- 
phocytes). This suggests that the decrease found 
in patients not treated prior to SI was not 
caused by a greater radiosensitivity of NK cells, 
but that immunoregulatory processes played the 
major role. 
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